Growth inhibitory effect of PARP inhibitor olaparib in gastric cancer cells

被引：0
|
作者：
Im, Seock-Ah
Min, Ahrum
Hur, Hyung-Seok
Yoon, Young-Kwang
Song, Sang Hyun
Riches, Lucy
Knights, Charlotte
Han, Sae-Won
Oh, Do-Youn
Wombwell, Helen
Kim, Tae-You
Gu, Yi
Lau, Alan
Bang, Yung-Jue
O'Connor, Mark
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-1775
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1775
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [1] Rapamycin sensitizes cancer cells to growth inhibition by the PARP inhibitor olaparib
    Osoegawa, Atsushi
    Gills, Joell J.
    Kawabata, Shigeru
    Sugio, Kenji
    Dennis, Phillip A.
    CANCER RESEARCH, 2014, 74 (19)
  • [2] Rapamycin sensitizes cancer cells to growth inhibition by the PARP inhibitor olaparib
    Osoegawa, Atsushi
    Gills, Joell J.
    Kawabata, Shigeru
    Dennis, Phillip A.
    ONCOTARGET, 2017, 8 (50) : 87044 - 87053
  • [3] THE ANTITUMOR EFFECT OF TALAPORFIN PHOTO DYNAMICTHERAPY (PDT) COMBINED WITH THE PARP INHIBITOR OLAPARIB FOR GASTRIC CANCER
    Tanaka, Mamoru
    Suzuki, Taketo
    Ichikawa, Hiroshi
    Nishie, Hirotada
    Kataoka, Hiromi
    GASTROENTEROLOGY, 2019, 156 (06) : S311 - S311
  • [4] ATM deficiency sensitizes gastric cancer cells to the PARP inhibitior olaparib
    Guo, Xiaoning
    Shen, Dihan
    Cheng, Wenxiang
    Bai, Yu
    Ni, Xing-Zhi
    Shen, Dan-Ping
    Zhang, Shirong
    Xie, Liang
    Knights, Charlotte
    Lau, Alan
    O'Connor, Mark
    Yin, Xiaolu
    Warford, Anthony
    Gu, Yi
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [5] ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib
    Wang, Chen
    Jette, Nicholas
    Moussienko, Daniel
    Bebb, D. Gwyn
    Lees-Miller, Susan P.
    TRANSLATIONAL ONCOLOGY, 2017, 10 (02): : 190 - 196
  • [6] PARP inhibitor olaparib induced differential protein expression in cervical cancer cells
    Rajawat, Jyotika
    Awasthi, Poorwa
    Banerjee, Monisha
    JOURNAL OF PROTEOMICS, 2023, 275
  • [7] Olaparib: a promising PARP inhibitor in ovarian cancer therapy
    Ying Chen
    Lei Zhang
    Quan Hao
    Archives of Gynecology and Obstetrics, 2013, 288 : 367 - 374
  • [8] Olaparib, PARP1 inhibitor in ovarian cancer
    Marchetti, Claudia
    Imperiale, Ludovica
    Gasparri, Maria Luisa
    Palaia, Innocenza
    Pignata, Sandro
    Boni, Terenzio
    Bellati, Filippo
    Panici, Pierluigi Benedetti
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (10) : 1575 - 1584
  • [9] Olaparib: a promising PARP inhibitor in ovarian cancer therapy
    Chen, Ying
    Zhang, Lei
    Hao, Quan
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 288 (02) : 367 - 374
  • [10] PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation
    Mao, Yize
    Huang, Xin
    Shuang, Zeyu
    Lin, Guohe
    Wang, Jun
    Duan, Fangting
    Chen, Jianlin
    Li, Shengping
    CANCER MEDICINE, 2018, 7 (04): : 1285 - 1296
12345